Clinical Trial Update: Quarterback 2b - Sequential Therapy With Reduced Dose Chemoradiotherapy for HPV Oropharynx Cancer [NA]

View source ↗

Summary

Clinical trial update for Quarterback 2b, a sequential therapy using reduced-dose chemoradiotherapy for locally advanced HPV-positive oropharyngeal cancer that …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hpv-positive Oropharyngeal Cancer

Snippet

Sponsor: Icahn School of Medicine at Mount Sinai | Conditions: Locally Advanced HPV Positive Oropharynx Cancer | NA | Status: ACTIVE_NOT_RECRUITING